INS and cancer: The molecule mechanisms of metformin's anti-cancer activities mostly rely on its ability to inhibit the LKB1-AMPK-mTOR signaling pathway and the cell division, to promote apoptosis and autophagy and down-regulate the circulating insulin [11–15].